Insider Purchases: Inside the Buy

Tag: Vanguard

Editorial illustration depicting a physician reviewing Pfizer's financial outlook alongside biotechnology imagery, DNA strands, oncology research, dividend metrics, insider buying indicators, and rising valuation charts.

💊 Pfizer (PFE): Why a Former Vanguard CEO Just Bought Nearly $1 Million of This 6.4% Dividend Stock

Pfizer has spent years under pressure following the collapse of pandemic-era revenues. Yet beneath the headlines, the company's non-COVID business is strengthening, oncology is expanding through Seagen, and two highly respected directors—including former Vanguard CEO and CIO Tim Buckley—recently invested nearly $2 million of their own money. We examine whether Wall Street is overlooking one of healthcare's most compelling value opportunities.

Read entire article

Tags: AlbertBourla, Biotech, buy or sell PFE, Deep Value, Dividend Investing, Dividend Stocks, FUNanc1al, GLP-1, Healthcare, Healthcare Stocks, HighDividend, Insider Buying, Insider Purchases, Long-Term Investing, MortimerBuckley, Oncology, PFE, Pfizer, Pharmaceuticals, Rare Diseases, risks buying PFE, Ronald Blaylock, Seagen, Tim Buckley, Vaccines, Value Investing, ValueInvesting, Vanguard, why buy PFE
Illustration of a modern chemical manufacturing facility with molecular structures blending into financial charts as a CEO purchases company stock ahead of Huntsman's proposed $12.5 billion merger with Olin, symbolizing long-term value investing.

🧪 Huntsman (HUN): CEO Buys $981K as Wall Street Overlooks a $12 Billion Chemical Merger

Huntsman isn't simply a cyclical chemical company anymore. Between repeated insider buying, a transformational $12.5 billion merger with Olin, trading at just 0.64x book value and more than $400 million in projected synergies, investors may be looking at one of the market's more intriguing industrial turnaround opportunities.

Read entire article

Tags: AQR Capital, buy or sell HUN, Chemicals, Contrarian Investment, Deep Value, Dividend Stocks, featured-insiders, FUNanc1al, FunStock Index, hub-insiders, HUN, Huntsman, Industrial Stocks, Industrials, Insider Buying, InsiderBuying, Investing, Merger Arbitrage, MergerOfEquals, NYSE, Olin, OlinCorporation, OlinHuntsman, OLN, Peter Huntsman, PeterHuntsman, risks buying HUN, Specialty Chemicals, Stocks, Turnaround, Turnaround Stocks, Value Investing, ValueInvesting, Vanguard, Wall Street, why buy HUN
Cartoon of Boeing jet preparing for takeoff while carrying heavy debt bags, with Tim Buckley as pilot and major institutions cheering.

Is Boeing Ready to Fly?

Boeing’s new director — ex-Vanguard CEO Tim Buckley — just bought nearly $500K of stock. With a $619B backlog and cash flow stabilizing, is this aerospace giant finally ready for liftoff… or more turbulence?

 

Read entire article

Tags: aerospace stocks, BA stock, Boeing, DIrector Buying, Director Insider Buying, Funanc1al, Funanc1al Contrarian Plays, Funanc1al for Investors, Funanc1al Insights, Funanc1al Investing, Funanc1al Turnaround Plays, Funanc1alAviation, Funanc1alEdge, Funanc1alFun, Funanc1alHumor, insider buying, institutional investors, investing insights, stock market, Tim Buckley, turnaround plays, Vanguard